Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Soraya Machado de Jesus, Rafael Santos Santana & Silvana Nair Leite. (2022) Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert Opinion on Drug Safety 21:1, pages 67-81.
Read now
Read now
Xingmei Duan, Minjie Mu, Junfeng Yan, Lan Bai, Lei Zhong, Yuxuan Zhu, Haixia Pan, Mei Zhang & Jianyou Shi. (2018) Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy. International Journal of Nanomedicine 13, pages 1443-1456.
Read now
Read now
Carmen Castaneda, Neil Minton, Melinda Mezo, Damien Hirsch, Lisa Phillips, Paul Sheehan, Robin McWilliams, May Chan-Liston, Robert Bwire & John Freeman. (2018) False-positive pregnancy tests in females of reproductive potential receiving lenalidomide in the United States. Leukemia & Lymphoma 59:4, pages 1025-1026.
Read now
Read now
Young Kim & Ingo GH Schmidt-Wolf. (2015) Lenalidomide in multiple myeloma. Expert Review of Anticancer Therapy 15:5, pages 491-497.
Read now
Read now
Michaela Semeraro & Lorenzo Galluzzi. (2014) Novel insights into the mechanism of action of lenalidomide. OncoImmunology 3:2.
Read now
Read now
Michaela Semeraro, Erika Vacchelli, Alexander Eggermont , Jerome Galon, L Zitvogel, G Kroemer & Lorenzo Galluzzi. (2013) Trial Watch: Lenalidomide-based immunochemotherapy. OncoImmunology 2:11.
Read now
Read now
Antonio Palumbo, John Freeman, Lilia Weiss & Pierre Fenaux. (2012) The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes. Expert Opinion on Drug Safety 11:1, pages 107-120.
Read now
Read now
Articles from other publishers (21)
Carla Minoia, Simonetta Viviani, Erica Silvestris, Simone Palini, Francesca Parissone, Giuseppe De Palma, Anna Fedina, Gennaro Cormio, Attilio Guarini, Guido Gini, Luigi Montano, Francesco Merli & Fedro Alessandro Peccatori. (2023) Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana. Frontiers in Oncology 13.
Crossref
Crossref
Marion Mueller & David J. Lewis. (2021) Implementation of a Pregnancy Prevention Programme (PPP) with a Controlled Distribution System (CDS) for the Generic Teratogenic Phthalimides Thalidomide, Lenalidomide and Pomalidomide. Therapeutic Innovation & Regulatory Science 55:6, pages 1155-1164.
Crossref
Crossref
Masato Komuro, Takahito Furuya, Yasukata Ohashi, Daisuke Watabe, Hisanaga Nomura, Ayumi Komuro, Akira Tabei, Seigo Sawamura, Hiroshi Hyakutake, Hiroko Kusu, Yuri Kita & Hiroyuki Terakado. (2021) Contamination of lenalidomide on blister packages after administration and its exposure countermeasures. Current Problems in Cancer 45:5, pages 100727.
Crossref
Crossref
Wejdan A. Shroukh, Douglas T. Steinke & Sarah C. Willis. (2020) Risk management of teratogenic medicines: A systematic review. Birth Defects Research 112:20, pages 1755-1786.
Crossref
Crossref
Erica Silvestris, Gennaro Cormio, Tetiana Skrypets, Miriam Dellino, Angelo Virgilio Paradiso, Attilio Guarini & Carla Minoia. (2020) Novel aspects on gonadotoxicity and fertility preservation in lymphoproliferative neoplasms. Critical Reviews in Oncology/Hematology 151, pages 102981.
Crossref
Crossref
Carla R.A. Batista, Adriana M. Godin, Ivo S.F. Melo, Giovanna M.E. Coura, Tamires C. Matsui, Marcela M.G.B. Dutra, Ana Mercy S. Brito, Wagner G. Canhestro, Ricardo J. Alves, Débora P. Araújo, Ângelo de Fátima, Renes R. Machado & Márcio M. Coelho. (2019) The phthalimide analogues N-3-hydroxypropylphthalimide and N-carboxymethyl-3-nitrophthalimide exhibit activity in experimental models of inflammatory and neuropathic pain. Pharmacological Reports 71:6, pages 1177-1183.
Crossref
Crossref
Arielle R. Nagler. (2019) Early Strides for Necessary Data-Driven Improvement in iPLEDGE. JAMA Dermatology 155:10, pages 1111.
Crossref
Crossref
Agustin Cota-Coronado, P. Berenice Ramírez-Rodríguez, Eduardo Padilla-Camberos, éNstor F. Díaz, Jose M. Flores-Fernández, Daniela Ávila-Gónzalez & N. Emmanuel Diaz-Martinez. (2019) Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine. Drug Discovery Today 24:1, pages 334-341.
Crossref
Crossref
Brian D. Edwards & Shelley Gandhi. 2018. Regulatory Toxicology in the European Union. Regulatory Toxicology in the European Union
129
162
.
Farshad Tahmasebi, Khawar Hussain, Georgina Smart, Manish Gupta & Upal Hossain. (2017) Successful pregnancy in the context of previously undiagnosed chronic lymphocytic leukaemia: A case report and literature review. Obstetric Medicine 10:4, pages 189-191.
Crossref
Crossref
Semra Paydas. (2016) Management of hemopoietic neoplasias during pregnancy. Critical Reviews in Oncology/Hematology 104, pages 52-64.
Crossref
Crossref
Hossam K. Mahmoud, Mohamed A. Samra & Gamal M. Fathy. (2016) Hematologic malignancies during pregnancy: A review. Journal of Advanced Research 7:4, pages 589-596.
Crossref
Crossref
Marc Rodger, Dawn Sheppard, Esteban Gándara & Alan Tinmouth. (2015) Haematological problems in obstetrics. Best Practice & Research Clinical Obstetrics & Gynaecology 29:5, pages 671-684.
Crossref
Crossref
María J Cejalvo & Javier de la Rubia. (2015) Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma. Future Oncology 11:11, pages 1643-1658.
Crossref
Crossref
Nada Hamad, David Kliman, O. Giles Best, Melody Caramins, Mark Hertzberg, Robert Lindeman, Ric Porter & Stephen P. Mulligan. (2015) Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management. British Journal of Haematology 168:3, pages 350-360.
Crossref
Crossref
Noa Lavi, Netanel A Horowitz & Benjamin Brenner. (2014) An Update on the Management of Hematologic Malignancies in Pregnancy. Women's Health 10:3, pages 255-266.
Crossref
Crossref
Gareth J. Morgan & Faith E. Davies. (2013) Role of thalidomide in the treatment of patients with multiple myeloma. Critical Reviews in Oncology/Hematology 88, pages S14-S22.
Crossref
Crossref
Maria Luisa Martínez-Frías. (2012) Talidomida: 50 años después. Medicina Clínica 139:1, pages 25-32.
Crossref
Crossref
Filemon Dela Cruz, Melissa Terry & Igor Matushansky. (2012) A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects. Differentiation 83:4, pages 220-230.
Crossref
Crossref
Benjamin Brenner, Irit Avivi & Michael Lishner. (2012) Haematological cancers in pregnancy. The Lancet 379:9815, pages 580-587.
Crossref
Crossref
Sonja A. Rasmussen & Jan M. Friedman. (2011) Emerging issues in teratology: An introduction. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 157:3, pages 147-149.
Crossref
Crossref